Systems biology approaches to unravelling neonatal sepsis and potential for precision diagnostics and therapeutics
Frontiers in Pharmacology · 30.04.2026 · 17
DOI: 10.3389/fphar.2026.1778409 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Pharmacology, online erschienen am 30.04.2026. Verfasst von Pearl Park und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Biology and Biochemistry, Simon Fraser University, Burnaby, BC, Canada. Die Arbeit nennt 121 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Canadian Institutes of Health Research.
Themen: Sepsis
Abstract (Originalsprache)
Sepsis is a major cause of global neonatal mortality, affecting 1.3 to 1.9 million neonates worldwide. Accurate diagnoses and effective treatment of sepsis during the onset is essential to improve outcomes. Current efforts to develop sensitive molecular biomarkers, however, are limited by the lack of accurate diagnostic tests, particularly the lack of sensitive viral testing or blood culture methods with low blood inoculums from small neonates. Consequently, antibiotic treatments are often misused, contributing to antimicrobial resistance among neonates exposed to unnecessary antibiotics. To improve the management of neonatal sepsis, a thorough understanding of early neonatal immune development and the pathophysiology of the disease is required. In this review, we summarize the current understanding of the newborn’s immune system based on different gestational ages and describe its influence on molecular mechanisms characterizing neonatal sepsis. We also focus on current endeavors for neonatal sepsis diagnosis and new approaches using omics-based biomarkers, highlighting their limitations and future directions for clinical applications. Lastly, we will discuss how utilizing systems immunology provides mechanistic insights and potential avenues towards therapeutics.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Molecular Biology and Biochemistry, Simon Fraser University, Burnaby, BC, Canada.
- British Columbia Children's Hospital Research Institute, Vancouver, BC, Canada.
- Prevention of Organ Failure (PROOF) Centre of Excellence, University of British Columbia, Vancouver, BC, Canada.
- Department of Microbiology and Immunology, The University of British Columbia, Vancouver, BC, Canada.
- Department of Pediatrics, Université Laval, Québec, QC, Canada.
- Department of Pediatrics, University of British Columbia, Vancouver, BC, Canada.
Förderung
- Canadian Institutes of Health Research
Zitieren
APA
Park, P., Ketabchi, N., Raymond, B. B., An, A. Y., Acton, E., Popescu, C. R., Lavoie, P. M., & Lee, A. H. Y. (2026). Systems biology approaches to unravelling neonatal sepsis and potential for precision diagnostics and therapeutics. Frontiers in Pharmacology, 17. https://doi.org/10.3389/fphar.2026.1778409
Vancouver
Park P, Ketabchi N, Raymond BB, An AY, Acton E, Popescu CR, et al. Systems biology approaches to unravelling neonatal sepsis and potential for precision diagnostics and therapeutics. Frontiers in Pharmacology. 2026;17. doi:10.3389/fphar.2026.1778409
BibTeX
@article{Park2026,
author = {Park, Pearl and Ketabchi, Negin and Raymond, Breanna B and An, Andy Y and Acton, Erica and Popescu, Constantin R and Lavoie, Pascal M and Lee, Amy H Y},
title = {Systems biology approaches to unravelling neonatal sepsis and potential for precision diagnostics and therapeutics},
journal = {Frontiers in Pharmacology},
year = {2026},
volume = {17},
doi = {10.3389/fphar.2026.1778409}
}
EUVIMED